“…For example, the anti-wrinkling effect of the botulinum toxin (Botox ® ), a toxin isolated from Clostridium botulinum bacteria, accounts for striking global sales of about $3 billion per year ( Clark et al., 2019 ). Among the biologically active compounds from animal venoms showing cosmeceuticals applications, we can cite the use of bee venom-containing cosmetics on facial wrinkles in human skin ( Han et al., 2015 ), and the inhibitory activity of melanogenesis of Argiotoxine-636 (ArgTX-636), a polyamine isolated from Argiope lobata spider venom ( Verdoni et al., 2016 ), including a deposited patent (US10064814B2) for skin whitening/depigmenting ( Mabrouk et al., 2018 ). Another example is the synthetic tripeptide [dipeptide diaminobutyroyl benzylamide diacetate (H-β-Ala-Pro-Dab-NHBzl x 2 AcOH)], commercialized as the cosmeceutical SYN ® -AKE (Pentapharm).…”